Peromyscus maniculatus bairdii isolate BW chromosome 18, HU_Pman_2.1.3, whole genome shotgun sequence.
Peromyscus maniculatus bairdii (prairie deer mouse)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Cricetidae; Neotominae; Peromyscus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM010896.2.\nAssembly name: HU_Pman_2.1.3\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Harvard University / Howard\nHughes Medical Institute on 2020/09/17. The original whole-genome\nshotgun project has the accession RCWR00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Harvard University / Howard Hughes\n Medical Institute\nAssembly Method :: AllPaths v. 2016-03\nAssembly Name :: HU_Pman_2.1.3\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 115.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Peromyscus maniculatus bairdii\n Annotation Release 102\nAnnotation Version :: 102\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
aldehyde dehydrogenase 1 family member L2, transcript variant X2
aldehyde dehydrogenase 1 family member L2, transcript variant X1
mitochondrial 10-formyltetrahydrofolate dehydrogenase
WASH complex subunit 4, transcript variant X1
WASH complex subunit 4, transcript variant X3
WASH complex subunit 4, transcript variant X2
WASH complex subunit 4, transcript variant X4
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2, transcript variant X2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2, transcript variant X1
DCC-interacting protein 13-beta isoform X2
DCC-interacting protein 13-beta isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chromosome 18 C12orf75 homolog, transcript variant X3
chromosome 18 C12orf75 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
chromosome 18 C12orf75 homolog, transcript variant X2
overexpressed in colon carcinoma 1 protein isoform X2
chromosome 18 C12orf75 homolog, transcript variant X1
overexpressed in colon carcinoma 1 protein isoform X1
uncharacterized LOC121823775, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121823775, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
NUAK family kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 88 samples with support for all annotated introns
NUAK family kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
NUAK family SNF1-like kinase 1 isoform X1
NUAK family SNF1-like kinase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RNA polymerase III subunit B, transcript variant X1
RNA polymerase III subunit B, transcript variant X2
DNA-directed RNA polymerase III subunit RPC2 isoform X1
DNA-directed RNA polymerase III subunit RPC2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC107402462, transcript variant X1
uncharacterized LOC107402462, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulatory factor X4, transcript variant X2
regulatory factor X4, transcript variant X1
regulatory factor X4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
regulatory factor X4, transcript variant X3
regulatory factor X4, transcript variant X4
RIC8 guanine nucleotide exchange factor B, transcript variant X1
RIC8 guanine nucleotide exchange factor B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RIC8 guanine nucleotide exchange factor B, transcript variant X5
RIC8 guanine nucleotide exchange factor B, transcript variant X4
RIC8 guanine nucleotide exchange factor B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RIC8 guanine nucleotide exchange factor B, transcript variant X2
RIC8 guanine nucleotide exchange factor B, transcript variant X3
RIC8 guanine nucleotide exchange factor B, transcript variant X9
RIC8 guanine nucleotide exchange factor B, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RIC8 guanine nucleotide exchange factor B, transcript variant X8
RIC8 guanine nucleotide exchange factor B, transcript variant X12
RIC8 guanine nucleotide exchange factor B, transcript variant X10
RIC8 guanine nucleotide exchange factor B, transcript variant X13
four and a half LIM domains protein 1-like, transcript variant X2
four and a half LIM domains protein 1-like, transcript variant X1
four and a half LIM domains protein 1-like
mitochondrial transcription termination factor 2, transcript variant X5
mitochondrial transcription termination factor 2, transcript variant X6
mitochondrial transcription termination factor 2, transcript variant X1
mitochondrial transcription termination factor 2, transcript variant X2
mitochondrial transcription termination factor 2, transcript variant X3
mitochondrial transcription termination factor 2, transcript variant X4
transcription termination factor 2, mitochondrial isoform X1
transcription termination factor 2, mitochondrial isoform X2
BTB domain containing 11, transcript variant X4
BTB domain containing 11, transcript variant X3
BTB domain containing 11, transcript variant X1
BTB domain containing 11, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X4
BTB domain containing 11, transcript variant X5
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
achaete-scute family bHLH transcription factor 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RNA 2',3'-cyclic phosphate and 5'-OH ligase
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
zinc finger protein 844-like, transcript variant X1
zinc finger protein 844-like, transcript variant X2
zinc finger protein 844-like, transcript variant X3
serine/threonine-protein kinase PLK1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
serine/threonine-protein kinase PLK1-like isoform X2
serine/threonine-protein kinase PLK1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
serine/threonine-protein kinase PLK1-like isoform X1
serine/threonine-protein kinase PLK1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
carbohydrate sulfotransferase 11, transcript variant X2
carbohydrate sulfotransferase 11, transcript variant X1
carbohydrate sulfotransferase 11, transcript variant X3
carbohydrate sulfotransferase 11 isoform X2
carbohydrate sulfotransferase 11 isoform X1
carbohydrate sulfotransferase 11 isoform X3
thioredoxin reductase 1, transcript variant X2
thioredoxin reductase 1, transcript variant X1
thioredoxin reductase 1, cytoplasmic isoform X1
thioredoxin reductase 1, cytoplasmic isoform X2
EP300 interacting inhibitor of differentiation 3
EP300-interacting inhibitor of differentiation 3
nuclear transcription factor Y subunit beta
host cell factor C2, transcript variant X3
host cell factor C2, transcript variant X4
host cell factor C2, transcript variant X2
host cell factor C2, transcript variant X5
host cell factor C2, transcript variant X1
glycosyltransferase 8 domain containing 2
glycosyltransferase 8 domain-containing protein 2
thymine DNA glycosylase, transcript variant X2
thymine DNA glycosylase, transcript variant X1
thymine DNA glycosylase, transcript variant X3
thymine DNA glycosylase, transcript variant X4
G/T mismatch-specific thymine DNA glycosylase isoform X2
G/T mismatch-specific thymine DNA glycosylase isoform X1
G/T mismatch-specific thymine DNA glycosylase isoform X3
heat shock protein 90 beta family member 1
tetratricopeptide repeat protein 41-like, transcript variant X5
tetratricopeptide repeat protein 41-like, transcript variant X6
tetratricopeptide repeat protein 41-like, transcript variant X2
tetratricopeptide repeat protein 41-like, transcript variant X1
tetratricopeptide repeat protein 41-like, transcript variant X3
tetratricopeptide repeat protein 41-like, transcript variant X7
tetratricopeptide repeat protein 41-like, transcript variant X4
tetratricopeptide repeat protein 41-like isoform X1
tetratricopeptide repeat protein 41-like isoform X2
tetratricopeptide repeat protein 41-like isoform X3
5'-nucleotidase domain containing 3, transcript variant X1
5'-nucleotidase domain-containing protein 3 isoform X1
5'-nucleotidase domain containing 3, transcript variant X2
5'-nucleotidase domain-containing protein 3 isoform X2
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
activity-dependent neuroprotector homeobox protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
activity-dependent neuroprotector homeobox protein 2-like
chromosome 18 C12orf42 homolog, transcript variant X1
chromosome 18 C12orf42 homolog, transcript variant X2
chromosome 18 C12orf42 homolog, transcript variant X3
uncharacterized protein C12orf42 homolog isoform X2
chromosome 18 C12orf42 homolog, transcript variant X5
chromosome 18 C12orf42 homolog, transcript variant X4
uncharacterized protein C12orf42 homolog isoform X1
uncharacterized protein C12orf42 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
achaete-scute family bHLH transcription factor 1
insulin like growth factor 1, transcript variant X7
insulin like growth factor 1, transcript variant X5
insulin like growth factor 1, transcript variant X6
insulin like growth factor 1, transcript variant X2
insulin like growth factor 1, transcript variant X4
insulin like growth factor 1, transcript variant X10
insulin like growth factor 1, transcript variant X11
insulin like growth factor 1, transcript variant X12
insulin like growth factor 1, transcript variant X9
insulin like growth factor 1, transcript variant X8
insulin like growth factor 1, transcript variant X1
insulin like growth factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PARP1 binding protein, transcript variant X2
PARP1 binding protein, transcript variant X1
PARP1 binding protein, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
WASH complex subunit 3, transcript variant X1
WASH complex subunit 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
DNA damage regulated autophagy modulator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA damage regulated autophagy modulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DNA damage regulated autophagy modulator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DNA damage regulated autophagy modulator 1, transcript variant X2
DNA damage-regulated autophagy modulator protein 1 isoform X2
DNA damage regulated autophagy modulator 1, transcript variant X1
DNA damage-regulated autophagy modulator protein 1 isoform X1
N-acetylglucosamine-1-phosphate transferase subunits alpha and beta
N-acetylglucosamine-1-phosphotransferase subunits alpha/beta
myosin binding protein C1, transcript variant X10
myosin binding protein C1, transcript variant X5
myosin binding protein C1, transcript variant X4
myosin binding protein C1, transcript variant X3
myosin binding protein C1, transcript variant X1
myosin binding protein C1, transcript variant X8
myosin binding protein C1, transcript variant X7
myosin binding protein C1, transcript variant X6
myosin binding protein C1, transcript variant X9
myosin-binding protein C, slow-type isoform X9
myosin-binding protein C, slow-type isoform X7
myosin-binding protein C, slow-type isoform X4
myosin-binding protein C, slow-type isoform X6
myosin-binding protein C, slow-type isoform X3
myosin-binding protein C, slow-type isoform X5
myosin-binding protein C, slow-type isoform X1
myosin-binding protein C, slow-type isoform X10
myosin binding protein C1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
myosin-binding protein C, slow-type isoform X8
myosin-binding protein C, slow-type isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
UTP20 small subunit processome component
small subunit processome component 20 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
sodium-coupled monocarboxylate transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor subfamily 1 group H member 4, transcript variant X7
nuclear receptor subfamily 1 group H member 4, transcript variant X6
nuclear receptor subfamily 1 group H member 4, transcript variant X5
nuclear receptor subfamily 1 group H member 4, transcript variant X4
nuclear receptor subfamily 1 group H member 4, transcript variant X3
nuclear receptor subfamily 1 group H member 4, transcript variant X2
nuclear receptor subfamily 1 group H member 4, transcript variant X1
uncharacterized LOC121823753, transcript variant X1
uncharacterized LOC121823753, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SCY1 like pseudokinase 2, transcript variant X5
SCY1 like pseudokinase 2, transcript variant X4
SCY1 like pseudokinase 2, transcript variant X3
SCY1 like pseudokinase 2, transcript variant X1
SCY1 like pseudokinase 2, transcript variant X2
actin related protein 6, transcript variant X1
actin related protein 6, transcript variant X2
UHRF1 binding protein 1 like, transcript variant X1
UHRF1 binding protein 1 like, transcript variant X2
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X1
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X3
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X10
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X9
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X8
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X7
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X6
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X2
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X4
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X5
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X1
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X2
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X3
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X4
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X8
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X9
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X6
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X10
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X5
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X13
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X11
ankyrin repeat and sterile alpha motif domain containing 1B, transcript variant X12
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X11
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X12
ankyrin repeat and sterile alpha motif domain-containing protein 1B isoform X13
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
apoptotic peptidase activating factor 1, transcript variant X1
apoptotic protease-activating factor 1 isoform X1
apoptotic peptidase activating factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
apoptotic protease-activating factor 1 isoform X2
apoptotic peptidase activating factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
apoptotic protease-activating factor 1 isoform X3
IKBKB interacting protein, transcript variant X2
IKBKB interacting protein, transcript variant X1
inhibitor of nuclear factor kappa-B kinase-interacting protein isoform X2
inhibitor of nuclear factor kappa-B kinase-interacting protein isoform X1
solute carrier family 25 member 3, transcript variant X2
solute carrier family 25 member 3, transcript variant X1
phosphate carrier protein, mitochondrial isoform X2
phosphate carrier protein, mitochondrial isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00563
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC121823798, transcript variant X2
uncharacterized LOC121823798, transcript variant X1
uncharacterized LOC107399647, transcript variant X5
uncharacterized LOC107399647, transcript variant X9
uncharacterized LOC107399647, transcript variant X7
uncharacterized LOC107399647, transcript variant X15
uncharacterized LOC107399647, transcript variant X4
uncharacterized LOC107399647, transcript variant X12
uncharacterized LOC107399647, transcript variant X13
uncharacterized LOC107399647, transcript variant X2
uncharacterized LOC107399647, transcript variant X10
uncharacterized LOC107399647, transcript variant X14
uncharacterized LOC107399647, transcript variant X18
uncharacterized LOC107399647, transcript variant X16
uncharacterized LOC107399647, transcript variant X1
uncharacterized LOC107399647, transcript variant X17
uncharacterized LOC107399647, transcript variant X11
uncharacterized LOC107399647, transcript variant X8
uncharacterized LOC107399647, transcript variant X3
uncharacterized LOC107399647, transcript variant X6
NEDD1 gamma-tubulin ring complex targeting factor, transcript variant X3
NEDD1 gamma-tubulin ring complex targeting factor, transcript variant X2
NEDD1 gamma-tubulin ring complex targeting factor, transcript variant X6
NEDD1 gamma-tubulin ring complex targeting factor, transcript variant X5
NEDD1 gamma-tubulin ring complex targeting factor, transcript variant X1
NEDD1 gamma-tubulin ring complex targeting factor, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00600
cilia and flagella associated protein 54
cilia- and flagella-associated protein 54
uncharacterized LOC121823756, transcript variant X1
uncharacterized LOC121823756, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 94 samples with support for all annotated introns
leukotriene A4 hydrolase, transcript variant X2
leukotriene A4 hydrolase, transcript variant X3
leukotriene A4 hydrolase, transcript variant X1
uncharacterized LOC121823669, transcript variant X3
uncharacterized LOC121823669, transcript variant X2
uncharacterized LOC121823669, transcript variant X1
coiled-coil domain-containing protein 38
small nuclear ribonucleoprotein polypeptide F, transcript variant X1
small nuclear ribonucleoprotein F isoform X1
small nuclear ribonucleoprotein polypeptide F, transcript variant X2
small nuclear ribonucleoprotein F isoform X2
ubiquitin specific peptidase 44, transcript variant X1
ubiquitin specific peptidase 44, transcript variant X8
ubiquitin specific peptidase 44, transcript variant X2
ubiquitin specific peptidase 44, transcript variant X7
ubiquitin specific peptidase 44, transcript variant X4
ubiquitin specific peptidase 44, transcript variant X3
ubiquitin specific peptidase 44, transcript variant X6
ubiquitin specific peptidase 44, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 44 isoform X1
ubiquitin carboxyl-terminal hydrolase 44 isoform X2
methionyl aminopeptidase 2, transcript variant X2
methionyl aminopeptidase 2, transcript variant X1
uncharacterized LOC107402647, transcript variant X1
uncharacterized LOC107402647, transcript variant X5
uncharacterized LOC107402647, transcript variant X4
uncharacterized LOC107402647, transcript variant X6
uncharacterized protein LOC107402647 isoform X1
uncharacterized protein LOC107402647 isoform X4
uncharacterized protein LOC107402647 isoform X5
uncharacterized LOC107402647, transcript variant X3
uncharacterized LOC107402647, transcript variant X2
uncharacterized protein LOC107402647 isoform X2
uncharacterized protein LOC107402647 isoform X3
vezatin, adherens junctions transmembrane protein, transcript variant X2
vezatin, adherens junctions transmembrane protein, transcript variant X1
vezatin, adherens junctions transmembrane protein, transcript variant X5
vezatin, adherens junctions transmembrane protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
vezatin, adherens junctions transmembrane protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
FYVE, RhoGEF and PH domain-containing protein 6
nuclear receptor subfamily 2 group C member 1, transcript variant X1
nuclear receptor subfamily 2 group C member 1, transcript variant X2
nuclear receptor subfamily 2 group C member 1
NADH:ubiquinone oxidoreductase subunit A12
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12
transmembrane and coiled-coil domain family 3, transcript variant X4
transmembrane and coiled-coil domain family 3, transcript variant X3
transmembrane and coiled-coil domain family 3, transcript variant X2
transmembrane and coiled-coil domain family 3, transcript variant X6
transmembrane and coiled-coil domain family 3, transcript variant X5
transmembrane and coiled-coil domain protein 3 isoform X2
transmembrane and coiled-coil domain family 3, transcript variant X8
transmembrane and coiled-coil domain family 3, transcript variant X1
transmembrane and coiled-coil domain family 3, transcript variant X9
transmembrane and coiled-coil domain family 3, transcript variant X7
transmembrane and coiled-coil domain protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
death domain-containing protein CRADD isoform X4
death domain-containing protein CRADD isoform X1
death domain-containing protein CRADD isoform X2
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X8
CASP2 and RIPK1 domain containing adaptor with death domain, transcript variant X6
death domain-containing protein CRADD isoform X5
death domain-containing protein CRADD isoform X3
suppressor of cytokine signaling 2, transcript variant X2
suppressor of cytokine signaling 2 isoform X2
suppressor of cytokine signaling 2, transcript variant X1
suppressor of cytokine signaling 2 isoform X1
suppressor of cytokine signaling 2, transcript variant X3
suppressor of cytokine signaling 2 isoform X3
mitochondrial ribosomal protein L42, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 102 samples with support for all annotated introns
mitochondrial ribosomal protein L42, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
39S ribosomal protein L42, mitochondrial
ubiquitin conjugating enzyme E2 N, transcript variant X1
ubiquitin-conjugating enzyme E2 N isoform X1
ubiquitin conjugating enzyme E2 N, transcript variant X2
ubiquitin-conjugating enzyme E2 N isoform X2
nudix hydrolase 4, transcript variant X2
nudix hydrolase 4, transcript variant X1
diphosphoinositol polyphosphate phosphohydrolase 2 isoform X2
diphosphoinositol polyphosphate phosphohydrolase 2 isoform X1
uncharacterized LOC121823729, transcript variant X2
uncharacterized LOC121823729, transcript variant X1
uncharacterized LOC107402922, transcript variant X3
uncharacterized LOC107402922, transcript variant X1
uncharacterized LOC107402922, transcript variant X5
uncharacterized LOC107402922, transcript variant X4
uncharacterized LOC107402922, transcript variant X2
uncharacterized LOC107402922, transcript variant X6
heterogeneous nuclear ribonucleoprotein A1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology and RhoGEF domain containing G7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; substituted 7 bases at 7 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pleckstrin homology domain-containing family G member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121823697, transcript variant X1
uncharacterized LOC121823697, transcript variant X2
coiled-coil domain-containing glutamate-rich protein 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
ATPase plasma membrane Ca2+ transporting 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
plasma membrane calcium-transporting ATPase 1
polypeptide N-acetylgalactosaminyltransferase 4
dual specificity phosphatase 6, transcript variant X2
dual specificity phosphatase 6, transcript variant X1
dual specificity protein phosphatase 6 isoform X1
dual specificity protein phosphatase 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC107401508, transcript variant X2
uncharacterized LOC107401508, transcript variant X1
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transmembrane O-mannosyltransferase targeting cadherins 3
centrosomal protein 290, transcript variant X1
centrosomal protein 290, transcript variant X2
centrosomal protein 290, transcript variant X3
centrosomal protein of 290 kDa isoform X1
centrosomal protein of 290 kDa isoform X2
centrosomal protein of 290 kDa isoform X3
chromosome 18 C12orf29 homolog, transcript variant X2
chromosome 18 C12orf29 homolog, transcript variant X1
uncharacterized protein C12orf29 homolog isoform X2
uncharacterized protein C12orf29 homolog isoform X1
chromosome 18 C12orf50 homolog, transcript variant X5
chromosome 18 C12orf50 homolog, transcript variant X4
chromosome 18 C12orf50 homolog, transcript variant X6
chromosome 18 C12orf50 homolog, transcript variant X2
chromosome 18 C12orf50 homolog, transcript variant X1
chromosome 18 C12orf50 homolog, transcript variant X3
uncharacterized protein C12orf50 homolog isoform X1
uncharacterized protein C12orf50 homolog isoform X3
uncharacterized protein C12orf50 homolog isoform X2
uncharacterized protein C12orf50 homolog isoform X4
uncharacterized protein C12orf50 homolog isoform X5
solute carrier family 6 member 15, transcript variant X1
solute carrier family 6 member 15, transcript variant X2
sodium-dependent neutral amino acid transporter B(0)AT2
uncharacterized LOC121823672, transcript variant X2
uncharacterized LOC121823672, transcript variant X1
leucine rich repeats and IQ motif containing 1, transcript variant X2
leucine rich repeats and IQ motif containing 1, transcript variant X1
leucine rich repeats and IQ motif containing 1, transcript variant X4
leucine rich repeats and IQ motif containing 1, transcript variant X5
leucine rich repeats and IQ motif containing 1, transcript variant X3
leucine rich repeats and IQ motif containing 1, transcript variant X6
leucine rich repeats and IQ motif containing 1, transcript variant X7
leucine-rich repeat and IQ domain-containing protein 1 isoform X1
leucine-rich repeat and IQ domain-containing protein 1 isoform X2
leucine-rich repeat and IQ domain-containing protein 1 isoform X3
leucine-rich repeat and IQ domain-containing protein 1 isoform X4
leucine-rich repeat and IQ domain-containing protein 1 isoform X5
leucine-rich repeat and IQ domain-containing protein 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras association domain-containing protein 9
MGAT4 family member C, transcript variant X2
MGAT4 family member C, transcript variant X3
MGAT4 family member C, transcript variant X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 44% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
uncharacterized LOC121823739, transcript variant X1
uncharacterized LOC121823739, transcript variant X2
uncharacterized LOC121823704, transcript variant X2
uncharacterized LOC121823704, transcript variant X1
transmembrane O-mannosyltransferase targeting cadherins 2
uncharacterized LOC121823668, transcript variant X2
uncharacterized LOC121823668, transcript variant X1
methyltransferase like 25, transcript variant X1
methyltransferase like 25, transcript variant X2
methyltransferase like 25, transcript variant X3
methyltransferase-like protein 25 isoform X1
methyltransferase-like protein 25 isoform X2
coiled-coil domain containing 59, transcript variant X2
thyroid transcription factor 1-associated protein 26 isoform X2
coiled-coil domain containing 59, transcript variant X1
thyroid transcription factor 1-associated protein 26 isoform X1
uncharacterized LOC121823759, transcript variant X2
uncharacterized LOC121823759, transcript variant X3
uncharacterized LOC121823759, transcript variant X1
PTPRF interacting protein alpha 2, transcript variant X2
PTPRF interacting protein alpha 2, transcript variant X1
PTPRF interacting protein alpha 2, transcript variant X6
PTPRF interacting protein alpha 2, transcript variant X5
PTPRF interacting protein alpha 2, transcript variant X7
PTPRF interacting protein alpha 2, transcript variant X4
PTPRF interacting protein alpha 2, transcript variant X3
PTPRF interacting protein alpha 2, transcript variant X9
PTPRF interacting protein alpha 2, transcript variant X15
PTPRF interacting protein alpha 2, transcript variant X13
PTPRF interacting protein alpha 2, transcript variant X11
PTPRF interacting protein alpha 2, transcript variant X16
PTPRF interacting protein alpha 2, transcript variant X14
PTPRF interacting protein alpha 2, transcript variant X18
PTPRF interacting protein alpha 2, transcript variant X10
PTPRF interacting protein alpha 2, transcript variant X12
PTPRF interacting protein alpha 2, transcript variant X17
PTPRF interacting protein alpha 2, transcript variant X19
PTPRF interacting protein alpha 2, transcript variant X8
PTPRF interacting protein alpha 2, transcript variant X30
PTPRF interacting protein alpha 2, transcript variant X33
PTPRF interacting protein alpha 2, transcript variant X35
PTPRF interacting protein alpha 2, transcript variant X26
PTPRF interacting protein alpha 2, transcript variant X32
PTPRF interacting protein alpha 2, transcript variant X20
PTPRF interacting protein alpha 2, transcript variant X28
PTPRF interacting protein alpha 2, transcript variant X31
PTPRF interacting protein alpha 2, transcript variant X34
PTPRF interacting protein alpha 2, transcript variant X22
PTPRF interacting protein alpha 2, transcript variant X24
PTPRF interacting protein alpha 2, transcript variant X29
PTPRF interacting protein alpha 2, transcript variant X21
PTPRF interacting protein alpha 2, transcript variant X25
PTPRF interacting protein alpha 2, transcript variant X27
PTPRF interacting protein alpha 2, transcript variant X36
PTPRF interacting protein alpha 2, transcript variant X23
PTPRF interacting protein alpha 2, transcript variant X37
acyl-CoA synthetase short chain family member 3
acyl-CoA synthetase short-chain family member 3, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC107401993, transcript variant X1
uncharacterized LOC107401993, transcript variant X2
lin-7 homolog A, crumbs cell polarity complex component, transcript variant X1
lin-7 homolog A, crumbs cell polarity complex component, transcript variant X4
lin-7 homolog A, crumbs cell polarity complex component, transcript variant X2
lin-7 homolog A, crumbs cell polarity complex component, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase receptor type Q
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 54% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 12A, transcript variant X1
protein phosphatase 1 regulatory subunit 12A, transcript variant X6
protein phosphatase 1 regulatory subunit 12A, transcript variant X2
protein phosphatase 1 regulatory subunit 12A, transcript variant X5
protein phosphatase 1 regulatory subunit 12A, transcript variant X4
protein phosphatase 1 regulatory subunit 12A, transcript variant X8
protein phosphatase 1 regulatory subunit 12A, transcript variant X3
protein phosphatase 1 regulatory subunit 12A, transcript variant X7
protein phosphatase 1 regulatory subunit 12A isoform X1
protein phosphatase 1 regulatory subunit 12A isoform X6
protein phosphatase 1 regulatory subunit 12A isoform X2
protein phosphatase 1 regulatory subunit 12A isoform X5
protein phosphatase 1 regulatory subunit 12A isoform X4
protein phosphatase 1 regulatory subunit 12A isoform X8
protein phosphatase 1 regulatory subunit 12A isoform X3
protein phosphatase 1 regulatory subunit 12A isoform X7
lys-63-specific deubiquitinase BRCC36-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 2 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC121823790, transcript variant X1
uncharacterized LOC121823790, transcript variant X3
uncharacterized LOC121823790, transcript variant X2
uncharacterized LOC121823790, transcript variant X4
neuron navigator 3, transcript variant X3
neuron navigator 3, transcript variant X2
neuron navigator 3, transcript variant X1
neuron navigator 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cysteine and glycine rich protein 2, transcript variant X3
cysteine and glycine rich protein 2, transcript variant X2
cysteine and glycine rich protein 2, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 17, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 17, transcript variant X1
uncharacterized LOC121823770, transcript variant X2
uncharacterized LOC121823770, transcript variant X1
uncharacterized LOC121823770, transcript variant X3
oxysterol binding protein like 8, transcript variant X1
oxysterol binding protein like 8, transcript variant X5
oxysterol binding protein like 8, transcript variant X4
oxysterol binding protein like 8, transcript variant X6
oxysterol binding protein like 8, transcript variant X7
oxysterol binding protein like 8, transcript variant X9
oxysterol binding protein like 8, transcript variant X3
oxysterol binding protein like 8, transcript variant X2
oxysterol binding protein like 8, transcript variant X8
oxysterol binding protein like 8, transcript variant X12
oxysterol binding protein like 8, transcript variant X14
oxysterol-binding protein-related protein 8 isoform X1
oxysterol-binding protein-related protein 8 isoform X3
oxysterol-binding protein-related protein 8 isoform X2
oxysterol-binding protein-related protein 8 isoform X4
oxysterol-binding protein-related protein 8 isoform X5
oxysterol-binding protein-related protein 8 isoform X6
oxysterol binding protein like 8, transcript variant X13
oxysterol-binding protein-related protein 8 isoform X9
oxysterol binding protein like 8, transcript variant X10
oxysterol binding protein like 8, transcript variant X11
oxysterol-binding protein-related protein 8 isoform X7
oxysterol-binding protein-related protein 8 isoform X8
uncharacterized LOC121823743, transcript variant X3
uncharacterized LOC121823743, transcript variant X2
uncharacterized LOC121823743, transcript variant X4
uncharacterized LOC121823743, transcript variant X1
oxysterol binding protein like 8, transcript variant X15
oxysterol-binding protein-related protein 8 isoform X10
Bardet-Biedl syndrome 10, transcript variant X3
Bardet-Biedl syndrome 10, transcript variant X1
Bardet-Biedl syndrome 10, transcript variant X2
Bardet-Biedl syndrome 10 protein isoform X3
Bardet-Biedl syndrome 10 protein isoform X1
Bardet-Biedl syndrome 10 protein isoform X2
Bardet-Biedl syndrome 10, transcript variant X42
Bardet-Biedl syndrome 10, transcript variant X45
Bardet-Biedl syndrome 10, transcript variant X46
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Bardet-Biedl syndrome 10, transcript variant X27
Bardet-Biedl syndrome 10, transcript variant X41
Bardet-Biedl syndrome 10, transcript variant X38
Bardet-Biedl syndrome 10, transcript variant X4
Bardet-Biedl syndrome 10, transcript variant X37
Bardet-Biedl syndrome 10, transcript variant X22
Bardet-Biedl syndrome 10, transcript variant X31
Bardet-Biedl syndrome 10, transcript variant X24
Bardet-Biedl syndrome 10, transcript variant X28
Bardet-Biedl syndrome 10, transcript variant X32
Bardet-Biedl syndrome 10, transcript variant X14
Bardet-Biedl syndrome 10, transcript variant X19
Bardet-Biedl syndrome 10, transcript variant X26
Bardet-Biedl syndrome 10, transcript variant X29
Bardet-Biedl syndrome 10, transcript variant X34
Bardet-Biedl syndrome 10, transcript variant X36
Bardet-Biedl syndrome 10, transcript variant X15
Bardet-Biedl syndrome 10, transcript variant X30
Bardet-Biedl syndrome 10, transcript variant X39
Bardet-Biedl syndrome 10, transcript variant X40
Bardet-Biedl syndrome 10, transcript variant X43
Bardet-Biedl syndrome 10, transcript variant X44
Bardet-Biedl syndrome 10, transcript variant X11
Bardet-Biedl syndrome 10, transcript variant X6
Bardet-Biedl syndrome 10, transcript variant X20
Bardet-Biedl syndrome 10, transcript variant X33
Bardet-Biedl syndrome 10, transcript variant X35
Bardet-Biedl syndrome 10, transcript variant X10
Bardet-Biedl syndrome 10, transcript variant X7
Bardet-Biedl syndrome 10, transcript variant X8
Bardet-Biedl syndrome 10, transcript variant X12
Bardet-Biedl syndrome 10, transcript variant X13
Bardet-Biedl syndrome 10, transcript variant X47
Bardet-Biedl syndrome 10, transcript variant X9
Bardet-Biedl syndrome 10, transcript variant X5
Bardet-Biedl syndrome 10, transcript variant X23
Bardet-Biedl syndrome 10, transcript variant X17
Bardet-Biedl syndrome 10, transcript variant X16
Bardet-Biedl syndrome 10, transcript variant X21
Bardet-Biedl syndrome 10, transcript variant X25
Bardet-Biedl syndrome 10, transcript variant X18
Bardet-Biedl syndrome 10, transcript variant X48
uncharacterized LOC121823719, transcript variant X2
uncharacterized LOC121823719, transcript variant X1
nucleosome assembly protein 1 like 1, transcript variant X1
nucleosome assembly protein 1 like 1, transcript variant X2
nucleosome assembly protein 1 like 1, transcript variant X3
nucleosome assembly protein 1 like 1, transcript variant X4
nucleosome assembly protein 1 like 1, transcript variant X6
nucleosome assembly protein 1 like 1, transcript variant X5
nucleosome assembly protein 1-like 1 isoform X1
nucleosome assembly protein 1-like 1 isoform X2
nucleosome assembly protein 1-like 1 isoform X4
nucleosome assembly protein 1-like 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00554
pleckstrin homology like domain family A member 1
pleckstrin homology-like domain family A member 1
uncharacterized LOC107400901, transcript variant X1
uncharacterized LOC107400901, transcript variant X2
uncharacterized LOC107400901, transcript variant X5
uncharacterized LOC107400901, transcript variant X6
uncharacterized LOC107400901, transcript variant X3
uncharacterized LOC107400901, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00432
uncharacterized LOC121823721, transcript variant X1
uncharacterized LOC121823721, transcript variant X3
uncharacterized LOC121823721, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
KRR1 small subunit processome component homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
potassium voltage-gated channel subfamily C member 2, transcript variant X6
potassium voltage-gated channel subfamily C member 2, transcript variant X8
potassium voltage-gated channel subfamily C member 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
potassium voltage-gated channel subfamily C member 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
potassium voltage-gated channel subfamily C member 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
potassium voltage-gated channel subfamily C member 2, transcript variant X3
potassium voltage-gated channel subfamily C member 2, transcript variant X1
potassium voltage-gated channel subfamily C member 2, transcript variant X4
potassium voltage-gated channel subfamily C member 2, transcript variant X5
potassium voltage-gated channel subfamily C member 2, transcript variant X10
potassium voltage-gated channel subfamily C member 2, transcript variant X2
potassium voltage-gated channel subfamily C member 2 isoform X5
potassium voltage-gated channel subfamily C member 2 isoform X3
potassium voltage-gated channel subfamily C member 2 isoform X1
potassium voltage-gated channel subfamily C member 2 isoform X2
potassium voltage-gated channel subfamily C member 2 isoform X4
potassium voltage-gated channel subfamily C member 2 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
thyrotropin releasing hormone degrading enzyme
thyrotropin-releasing hormone-degrading ectoenzyme
tryptophan hydroxylase 2, transcript variant X1
tryptophan hydroxylase 2, transcript variant X2
TBC1 domain family member 15, transcript variant X2
TBC1 domain family member 15, transcript variant X1
transmembrane protein 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane protein 19, transcript variant X1
transmembrane protein 19, transcript variant X4
transmembrane protein 19, transcript variant X3
transmembrane protein 19, transcript variant X6
transmembrane protein 19, transcript variant X5
THAP domain-containing protein 2 isoform X3
zinc finger C3H1-type containing, transcript variant X1
zinc finger C3H1 domain-containing protein isoform X1
zinc finger C3H1-type containing, transcript variant X2
zinc finger C3H1 domain-containing protein isoform X2
leucine rich repeat containing G protein-coupled receptor 5, transcript variant X2
leucine rich repeat containing G protein-coupled receptor 5, transcript variant X1
leucine-rich repeat-containing G-protein coupled receptor 5 isoform X2
leucine-rich repeat-containing G-protein coupled receptor 5 isoform X1
protein tyrosine phosphatase receptor type R, transcript variant X1
receptor-type tyrosine-protein phosphatase R isoform X1
transcription initiation factor TFIID subunit 7-like
protein tyrosine phosphatase receptor type R, transcript variant X3
receptor-type tyrosine-protein phosphatase R isoform X3
protein tyrosine phosphatase receptor type R, transcript variant X2
receptor-type tyrosine-protein phosphatase R isoform X2
protein tyrosine phosphatase receptor type B, transcript variant X1
receptor-type tyrosine-protein phosphatase beta isoform X1
protein tyrosine phosphatase receptor type B, transcript variant X2
receptor-type tyrosine-protein phosphatase beta isoform X2
uncharacterized LOC121823805, transcript variant X2
uncharacterized LOC121823805, transcript variant X1
uncharacterized LOC121823805, transcript variant X3
potassium calcium-activated channel subfamily M regulatory beta subunit 4
calcium-activated potassium channel subunit beta-4
CCR4-NOT transcription complex subunit 2, transcript variant X5
CCR4-NOT transcription complex subunit 2, transcript variant X1
CCR4-NOT transcription complex subunit 2, transcript variant X2
CCR4-NOT transcription complex subunit 2, transcript variant X3
CCR4-NOT transcription complex subunit 2, transcript variant X4
CCR4-NOT transcription complex subunit 2, transcript variant X7
CCR4-NOT transcription complex subunit 2, transcript variant X8
CCR4-NOT transcription complex subunit 2, transcript variant X6
CCR4-NOT transcription complex subunit 2 isoform X4
CCR4-NOT transcription complex subunit 2 isoform X1
CCR4-NOT transcription complex subunit 2 isoform X2
CCR4-NOT transcription complex subunit 2 isoform X3
CCR4-NOT transcription complex subunit 2 isoform X5
CCR4-NOT transcription complex subunit 2 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 5 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
RAB3A interacting protein, transcript variant X1
RAB3A interacting protein, transcript variant X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
leucine-rich repeat-containing protein 10
chaperonin containing TCP1 subunit 2, transcript variant X2
chaperonin containing TCP1 subunit 2, transcript variant X1
T-complex protein 1 subunit beta isoform X2
T-complex protein 1 subunit beta isoform X1
fibroblast growth factor receptor substrate 2, transcript variant X1
fibroblast growth factor receptor substrate 2, transcript variant X2
fibroblast growth factor receptor substrate 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 9 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
integrin subunit alpha 7, transcript variant X1
integrin subunit alpha 7, transcript variant X4
integrin subunit alpha 7, transcript variant X2
integrin subunit alpha 7, transcript variant X3
biogenesis of lysosomal organelles complex 1 subunit 1
biogenesis of lysosome-related organelles complex 1 subunit 1
retinol dehydrogenase 5, transcript variant X2
retinol dehydrogenase 5, transcript variant X1
uncharacterized LOC121823782, transcript variant X2
uncharacterized LOC121823782, transcript variant X1
uncharacterized LOC121823782, transcript variant X3
SAP domain containing ribonucleoprotein, transcript variant X3
SAP domain-containing ribonucleoprotein isoform X2
SAP domain containing ribonucleoprotein, transcript variant X2
SAP domain containing ribonucleoprotein, transcript variant X1
SAP domain-containing ribonucleoprotein isoform X1
ORMDL sphingolipid biosynthesis regulator 2, transcript variant X1
ORMDL sphingolipid biosynthesis regulator 2, transcript variant X2
DnaJ heat shock protein family (Hsp40) member C14
transmembrane protein 198-like, transcript variant X3
transmembrane protein 198-like, transcript variant X2
transmembrane protein 198-like, transcript variant X5
transmembrane protein 198-like, transcript variant X1
transmembrane protein 198-like, transcript variant X4
transmembrane protein 198-like, transcript variant X6
transmembrane protein 198-like isoform X1
transmembrane protein 198-like isoform X2
transmembrane protein 198-like isoform X3
PYM homolog 1, exon junction complex associated factor, transcript variant X3
PYM homolog 1, exon junction complex associated factor, transcript variant X4
PYM homolog 1, exon junction complex associated factor, transcript variant X1
PYM homolog 1, exon junction complex associated factor, transcript variant X2
diacylglycerol kinase alpha, transcript variant X1
diacylglycerol kinase alpha, transcript variant X3
diacylglycerol kinase alpha, transcript variant X2
diacylglycerol kinase alpha, transcript variant X4
diacylglycerol kinase alpha, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
cyclin dependent kinase 2, transcript variant X1
cyclin dependent kinase 2, transcript variant X2
cyclin dependent kinase 2, transcript variant X3
sulfite oxidase, mitochondrial isoform X1
sulfite oxidase, mitochondrial isoform X2
IKAROS family zinc finger 4, transcript variant X2
uncharacterized LOC107402494, transcript variant X1
uncharacterized LOC107402494, transcript variant X2
IKAROS family zinc finger 4, transcript variant X1
IKAROS family zinc finger 4, transcript variant X3
IKAROS family zinc finger 4, transcript variant X4
IKAROS family zinc finger 4, transcript variant X6
IKAROS family zinc finger 4, transcript variant X5
erb-b2 receptor tyrosine kinase 3, transcript variant X1
erb-b2 receptor tyrosine kinase 3, transcript variant X2
receptor tyrosine-protein kinase erbB-3 isoform X1
receptor tyrosine-protein kinase erbB-3 isoform X2
uncharacterized LOC121823778, transcript variant X11
uncharacterized LOC121823778, transcript variant X8
uncharacterized LOC121823778, transcript variant X10
uncharacterized LOC121823778, transcript variant X4
uncharacterized LOC121823778, transcript variant X7
uncharacterized LOC121823778, transcript variant X5
uncharacterized LOC121823778, transcript variant X1
uncharacterized LOC121823778, transcript variant X2
uncharacterized LOC121823778, transcript variant X6
uncharacterized LOC121823778, transcript variant X9
uncharacterized LOC121823778, transcript variant X3
uncharacterized LOC121823787, transcript variant X1
uncharacterized LOC121823787, transcript variant X2
zinc finger CCCH-type containing 10, transcript variant X1
zinc finger CCCH-type containing 10, transcript variant X2
zinc finger CCCH domain-containing protein 10
myosin light chain 6, transcript variant X3
myosin light chain 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
myosin light chain 6, transcript variant X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X3
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X6
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X5
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X8
SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2, transcript variant X7
SWI/SNF complex subunit SMARCC2 isoform X4
SWI/SNF complex subunit SMARCC2 isoform X8
SWI/SNF complex subunit SMARCC2 isoform X3
SWI/SNF complex subunit SMARCC2 isoform X6
SWI/SNF complex subunit SMARCC2 isoform X2
SWI/SNF complex subunit SMARCC2 isoform X7
SWI/SNF complex subunit SMARCC2 isoform X5
SWI/SNF complex subunit SMARCC2 isoform X1
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC121823784, transcript variant X1
uncharacterized LOC121823784, transcript variant X2
ring finger protein 41, transcript variant X1
ring finger protein 41, transcript variant X6
ring finger protein 41, transcript variant X5
ring finger protein 41, transcript variant X4
ring finger protein 41, transcript variant X2
ring finger protein 41, transcript variant X7
ring finger protein 41, transcript variant X3
E3 ubiquitin-protein ligase NRDP1 isoform X3
E3 ubiquitin-protein ligase NRDP1 isoform X2
E3 ubiquitin-protein ligase NRDP1 isoform X1
E3 ubiquitin-protein ligase NRDP1 isoform X4
nucleic acid binding protein 2, transcript variant X5
nucleic acid binding protein 2, transcript variant X2
nucleic acid binding protein 2, transcript variant X6
nucleic acid binding protein 2, transcript variant X1
nucleic acid binding protein 2, transcript variant X3
nucleic acid binding protein 2, transcript variant X4
solute carrier family 39 member 5, transcript variant X3
solute carrier family 39 member 5, transcript variant X1
solute carrier family 39 member 5, transcript variant X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C
coenzyme Q-binding protein COQ10 homolog A, mitochondrial
canopy FGF signaling regulator 2, transcript variant X2
canopy FGF signaling regulator 2, transcript variant X1
poly(A) specific ribonuclease subunit PAN2, transcript variant X3
poly(A) specific ribonuclease subunit PAN2, transcript variant X4
poly(A) specific ribonuclease subunit PAN2, transcript variant X1
poly(A) specific ribonuclease subunit PAN2, transcript variant X2
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X2
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X3
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X1
interleukin 23 subunit alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
interleukin 23 subunit alpha, transcript variant X2
interleukin 23 subunit alpha, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
interleukin 23 subunit alpha, transcript variant X4
signal transducer and activator of transcription 2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein phosphatase PP1-alpha catalytic subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
cleavage and polyadenylation specific factor 6
cleavage and polyadenylation specificity factor subunit 6
uncharacterized LOC121823726, transcript variant X2
uncharacterized LOC121823726, transcript variant X3
uncharacterized LOC121823726, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
carboxypeptidase M, transcript variant X1
carboxypeptidase M, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 90% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00007
solute carrier family 35 member E3, transcript variant X2
solute carrier family 35 member E3, transcript variant X1
solute carrier family 35 member E3 isoform X2
solute carrier family 35 member E3 isoform X1
solute carrier family 35 member E3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
solute carrier family 35 member E3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
nuclear pore complex protein Nup107 isoform X1
nuclear pore complex protein Nup107 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC121823690, transcript variant X1
uncharacterized LOC121823690, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00045
Mdm1 nuclear protein, transcript variant X2
Mdm1 nuclear protein, transcript variant X1
Mdm1 nuclear protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
dual specificity tyrosine phosphorylation regulated kinase 2, transcript variant X2
dual specificity tyrosine phosphorylation regulated kinase 2, transcript variant X1
dual specificity tyrosine-phosphorylation-regulated kinase 2
uncharacterized LOC121823803, transcript variant X4
uncharacterized LOC121823803, transcript variant X2
uncharacterized LOC121823803, transcript variant X1
uncharacterized LOC121823803, transcript variant X3
cullin associated and neddylation dissociated 1
cullin-associated NEDD8-dissociated protein 1
uncharacterized LOC121823794, transcript variant X1
uncharacterized LOC121823794, transcript variant X2
glutamate receptor interacting protein 1, transcript variant X13
glutamate receptor interacting protein 1, transcript variant X11
glutamate receptor interacting protein 1, transcript variant X14
glutamate receptor interacting protein 1, transcript variant X18
glutamate receptor-interacting protein 1 isoform X11
glutamate receptor-interacting protein 1 isoform X13
glutamate receptor-interacting protein 1 isoform X14
glutamate receptor-interacting protein 1 isoform X18
glutamate receptor interacting protein 1, transcript variant X8
glutamate receptor interacting protein 1, transcript variant X12
glutamate receptor interacting protein 1, transcript variant X9
glutamate receptor interacting protein 1, transcript variant X15
glutamate receptor interacting protein 1, transcript variant X17
glutamate receptor-interacting protein 1 isoform X8
glutamate receptor-interacting protein 1 isoform X12
glutamate receptor-interacting protein 1 isoform X9
glutamate receptor-interacting protein 1 isoform X15
glutamate receptor-interacting protein 1 isoform X17
glutamate receptor interacting protein 1, transcript variant X4
glutamate receptor interacting protein 1, transcript variant X7
glutamate receptor interacting protein 1, transcript variant X6
glutamate receptor interacting protein 1, transcript variant X16
glutamate receptor-interacting protein 1 isoform X4
glutamate receptor-interacting protein 1 isoform X6
glutamate receptor-interacting protein 1 isoform X7
glutamate receptor-interacting protein 1 isoform X16
glutamate receptor interacting protein 1, transcript variant X1
glutamate receptor interacting protein 1, transcript variant X3
glutamate receptor interacting protein 1, transcript variant X5
glutamate receptor interacting protein 1, transcript variant X2
glutamate receptor interacting protein 1, transcript variant X10
glutamate receptor-interacting protein 1 isoform X1
glutamate receptor-interacting protein 1 isoform X3
glutamate receptor-interacting protein 1 isoform X5
glutamate receptor-interacting protein 1 isoform X2
glutamate receptor-interacting protein 1 isoform X10
interleukin 1 receptor associated kinase 3, transcript variant X2
interleukin 1 receptor associated kinase 3, transcript variant X1
interleukin 1 receptor associated kinase 3, transcript variant X3
interleukin-1 receptor-associated kinase 3 isoform X2
interleukin-1 receptor-associated kinase 3 isoform X1
interleukin-1 receptor-associated kinase 3 isoform X3
transmembrane BAX inhibitor motif containing 4, transcript variant X1
transmembrane BAX inhibitor motif containing 4, transcript variant X2
LLP homolog, long-term synaptic facilitation factor, transcript variant X2
LLP homolog, long-term synaptic facilitation factor, transcript variant X1
mitochondrial import inner membrane translocase subunit Tim9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
high mobility group AT-hook 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
high mobility group protein HMGI-C isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
high mobility group AT-hook 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
high mobility group protein HMGI-C isoform X2
methionine sulfoxide reductase B3, transcript variant X1
methionine sulfoxide reductase B3, transcript variant X3
methionine sulfoxide reductase B3, transcript variant X2
methionine-R-sulfoxide reductase B3 isoform X1
methionine-R-sulfoxide reductase B3 isoform X2
uncharacterized LOC107400750, transcript variant X1
uncharacterized LOC107400750, transcript variant X2
TBC1 domain family member 30, transcript variant X2
TBC1 domain family member 30, transcript variant X1
TBC1 domain family member 30, transcript variant X4
TBC1 domain family member 30, transcript variant X3
ras association domain-containing protein 3
TANK binding kinase 1, transcript variant X2
TANK binding kinase 1, transcript variant X1
exportin for tRNA, transcript variant X2
exportin for tRNA, transcript variant X1
uncharacterized protein C12orf56 homolog
KICSTOR subunit 2, transcript variant X1
KICSTOR subunit 2, transcript variant X2
KICSTOR subunit 2, transcript variant X3
SLIT-ROBO Rho GTPase activating protein 1, transcript variant X1
SLIT-ROBO Rho GTPase activating protein 1, transcript variant X2
SLIT-ROBO Rho GTPase activating protein 1, transcript variant X3
SLIT-ROBO Rho GTPase-activating protein 1 isoform X2
SLIT-ROBO Rho GTPase-activating protein 1 isoform X1
SLIT-ROBO Rho GTPase-activating protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sentrin-specific protease 2-like
ribitol xylosyltransferase 1, transcript variant X1
ribitol xylosyltransferase 1, transcript variant X2
ribitol-5-phosphate xylosyltransferase 1 isoform X1
ribitol-5-phosphate xylosyltransferase 1 isoform X2
protein phosphatase, Mg2+/Mn2+ dependent 1H
MON2 homolog, regulator of endosome-to-Golgi trafficking, transcript variant X5
MON2 homolog, regulator of endosome-to-Golgi trafficking, transcript variant X3
MON2 homolog, regulator of endosome-to-Golgi trafficking, transcript variant X4
MON2 homolog, regulator of endosome-to-Golgi trafficking, transcript variant X2
MON2 homolog, regulator of endosome-to-Golgi trafficking, transcript variant X1
MON2 homolog, regulator of endosome-to-Golgi trafficking, transcript variant X6
ubiquitin specific peptidase 15, transcript variant X2
ubiquitin specific peptidase 15, transcript variant X1
ubiquitin specific peptidase 15, transcript variant X3
ubiquitin specific peptidase 15, transcript variant X4
ubiquitin specific peptidase 15, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 15 isoform X2
ubiquitin carboxyl-terminal hydrolase 15 isoform X1
ubiquitin carboxyl-terminal hydrolase 15 isoform X3
ubiquitin carboxyl-terminal hydrolase 15 isoform X4
ubiquitin specific peptidase 15, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 15 isoform X5
ubiquitin specific peptidase 15, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 15 isoform X6
TAFA chemokine like family member 2, transcript variant X3
uncharacterized LOC121823679, transcript variant X1
TAFA chemokine like family member 2, transcript variant X2
TAFA chemokine like family member 2, transcript variant X1
chemokine-like protein TAFA-2 isoform X1
uncharacterized LOC121823679, transcript variant X2
TAFA chemokine like family member 2, transcript variant X4
chemokine-like protein TAFA-2 isoform X2
TAFA chemokine like family member 2, transcript variant X5
chemokine-like protein TAFA-2 isoform X3
uncharacterized LOC121823769, transcript variant X1
uncharacterized LOC121823769, transcript variant X2
uncharacterized LOC121823749, transcript variant X2
uncharacterized LOC121823749, transcript variant X1
solute carrier family 16 member 7, transcript variant X4
solute carrier family 16 member 7, transcript variant X2
solute carrier family 16 member 7, transcript variant X3
solute carrier family 16 member 7, transcript variant X1
leucine rich repeats and immunoglobulin like domains 3
leucine-rich repeats and immunoglobulin-like domains protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog isoform X7
mitochondrial inner membrane protease ATP23 homolog isoform X2
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog isoform X5
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X5
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog isoform X4
mitochondrial inner membrane protease ATP23 homolog isoform X1
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog isoform X8
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X4
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 87 samples with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog isoform X3
ATP23 metallopeptidase and ATP synthase assembly factor homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mitochondrial inner membrane protease ATP23 homolog isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
CTD small phosphatase 2, transcript variant X1
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 isoform X1
CTD small phosphatase 2, transcript variant X2
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Ts translation elongation factor, mitochondrial
EEF1A lysine methyltransferase 3, transcript variant X2
EEF1A lysine methyltransferase 3, transcript variant X1
EEF1A lysine methyltransferase 3, transcript variant X3
EEF1A lysine methyltransferase 3 isoform X2
EEF1A lysine methyltransferase 3 isoform X1
EEF1A lysine methyltransferase 3 isoform X3
methyltransferase 1, tRNA methylguanosine
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
membrane associated ring-CH-type finger 9
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2, transcript variant X1
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2, transcript variant X2
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 isoform X1
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 isoform X2
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2, transcript variant X3
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 isoform X3
OS9 endoplasmic reticulum lectin, transcript variant X1
OS9 endoplasmic reticulum lectin, transcript variant X2
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X4
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X5
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X10
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X7
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X9
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X3
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X1
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
beta-1,4-N-acetyl-galactosaminyltransferase 1, transcript variant X2
beta-1,4 N-acetylgalactosaminyltransferase 1 isoform X2
beta-1,4 N-acetylgalactosaminyltransferase 1 isoform X3
beta-1,4 N-acetylgalactosaminyltransferase 1 isoform X1
Rho guanine nucleotide exchange factor 25, transcript variant X4
Rho guanine nucleotide exchange factor 25, transcript variant X1
Rho guanine nucleotide exchange factor 25, transcript variant X3
Rho guanine nucleotide exchange factor 25, transcript variant X2
Rho guanine nucleotide exchange factor 25, transcript variant X6
Rho guanine nucleotide exchange factor 25, transcript variant X5
rho guanine nucleotide exchange factor 25 isoform X3
rho guanine nucleotide exchange factor 25 isoform X4
rho guanine nucleotide exchange factor 25 isoform X1
rho guanine nucleotide exchange factor 25 isoform X2
rho guanine nucleotide exchange factor 25 isoform X6
rho guanine nucleotide exchange factor 25 isoform X5
deltex E3 ubiquitin ligase 3, transcript variant X1
deltex E3 ubiquitin ligase 3, transcript variant X3
deltex E3 ubiquitin ligase 3, transcript variant X2
probable E3 ubiquitin-protein ligase DTX3 isoform X1
probable E3 ubiquitin-protein ligase DTX3 isoform X2
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
phosphatidylinositol 5-phosphate 4-kinase type-2 gamma
dynactin subunit 2, transcript variant X1
dynactin subunit 2, transcript variant X2
dynactin subunit 2, transcript variant X3
methyl-CpG binding domain protein 6, transcript variant X9
methyl-CpG binding domain protein 6, transcript variant X8
methyl-CpG binding domain protein 6, transcript variant X7
methyl-CpG binding domain protein 6, transcript variant X5
methyl-CpG binding domain protein 6, transcript variant X6
methyl-CpG binding domain protein 6, transcript variant X1
methyl-CpG binding domain protein 6, transcript variant X2
methyl-CpG binding domain protein 6, transcript variant X3
methyl-CpG binding domain protein 6, transcript variant X4
methyl-CpG-binding domain protein 6 isoform X2
methyl-CpG-binding domain protein 6 isoform X1
methyl-CpG binding domain protein 6, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
methyl-CpG-binding domain protein 6 isoform X3
DNA damage inducible transcript 3, transcript variant X1
DNA damage inducible transcript 3, transcript variant X2
DNA damage-inducible transcript 3 protein
methionyl-tRNA synthetase 1, transcript variant X2
methionyl-tRNA synthetase 1, transcript variant X1
methionine--tRNA ligase, cytoplasmic isoform X2
methionine--tRNA ligase, cytoplasmic isoform X1
Rho GTPase activating protein 9, transcript variant X1
rho GTPase-activating protein 9 isoform X1
Rho GTPase activating protein 9, transcript variant X2
Rho GTPase activating protein 9, transcript variant X3
rho GTPase-activating protein 9 isoform X2
uncharacterized LOC121823685, transcript variant X1
uncharacterized LOC121823685, transcript variant X2
GLI family zinc finger 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
GLI family zinc finger 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GLI family zinc finger 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GLI family zinc finger 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
R3H domain containing 2, transcript variant X2
R3H domain containing 2, transcript variant X7
R3H domain containing 2, transcript variant X10
R3H domain containing 2, transcript variant X1
R3H domain containing 2, transcript variant X5
R3H domain containing 2, transcript variant X11
R3H domain containing 2, transcript variant X6
R3H domain containing 2, transcript variant X13
R3H domain containing 2, transcript variant X9
R3H domain containing 2, transcript variant X15
R3H domain containing 2, transcript variant X12
R3H domain containing 2, transcript variant X16
R3H domain containing 2, transcript variant X8
R3H domain containing 2, transcript variant X14
R3H domain containing 2, transcript variant X3
R3H domain containing 2, transcript variant X4
R3H domain-containing protein 2 isoform X1
R3H domain-containing protein 2 isoform X2
R3H domain-containing protein 2 isoform X6
R3H domain-containing protein 2 isoform X3
R3H domain-containing protein 2 isoform X8
R3H domain-containing protein 2 isoform X5
R3H domain-containing protein 2 isoform X10
R3H domain-containing protein 2 isoform X7
R3H domain-containing protein 2 isoform X11
R3H domain-containing protein 2 isoform X4
R3H domain-containing protein 2 isoform X9
SH3 and cysteine rich domain 3, transcript variant X4
SH3 and cysteine rich domain 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SH3 and cysteine rich domain 3, transcript variant X2
SH3 and cysteine rich domain 3, transcript variant X5
SH3 and cysteine rich domain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
SH3 and cysteine-rich domain-containing protein 3
NDUFA4 mitochondrial complex associated like 2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2
serine hydroxymethyltransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
prolow-density lipoprotein receptor-related protein 1
signal transducer and activator of transcription 6
NGFI-A binding protein 2, transcript variant X2
NGFI-A binding protein 2, transcript variant X1
nuclear envelope integral membrane protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 6 ESTs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain containing 39
zinc finger and BTB domain-containing protein 39
retinol dehydrogenase 16, transcript variant X1
retinol dehydrogenase 16, transcript variant X2
retinol dehydrogenase 7-like, transcript variant X3
retinol dehydrogenase 7-like, transcript variant X5
retinol dehydrogenase 16-like isoform X3
retinol dehydrogenase 7-like, transcript variant X2
retinol dehydrogenase 7-like, transcript variant X1
retinol dehydrogenase 7-like, transcript variant X4
retinol dehydrogenase 16-like isoform X2
short chain dehydrogenase/reductase family 9C member 7
short-chain dehydrogenase/reductase family 9C member 7
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
17-beta-hydroxysteroid dehydrogenase type 6, transcript variant X4
17-beta-hydroxysteroid dehydrogenase type 6, transcript variant X1
17-beta-hydroxysteroid dehydrogenase type 6, transcript variant X2
17-beta-hydroxysteroid dehydrogenase type 6, transcript variant X3
17-beta-hydroxysteroid dehydrogenase type 6, transcript variant X5
17-beta-hydroxysteroid dehydrogenase type 6, transcript variant X6
17-beta-hydroxysteroid dehydrogenase type 6
nascent polypeptide associated complex subunit alpha, transcript variant X1
nascent polypeptide associated complex subunit alpha, transcript variant X3
nascent polypeptide associated complex subunit alpha, transcript variant X2
nascent polypeptide associated complex subunit alpha, transcript variant X4
nascent polypeptide associated complex subunit alpha, transcript variant X5
nascent polypeptide-associated complex subunit alpha isoform X1
nascent polypeptide-associated complex subunit alpha isoform X3
nascent polypeptide-associated complex subunit alpha isoform X2
nascent polypeptide-associated complex subunit alpha isoform X4
nascent polypeptide-associated complex subunit alpha isoform X5
prostaglandin E synthase 3, transcript variant X1
prostaglandin E synthase 3, transcript variant X2
ATP synthase subunit beta, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00273
bromodomain adjacent to zinc finger domain 2A, transcript variant X4
bromodomain adjacent to zinc finger domain 2A, transcript variant X1
bromodomain adjacent to zinc finger domain 2A, transcript variant X6
bromodomain adjacent to zinc finger domain 2A, transcript variant X5
bromodomain adjacent to zinc finger domain 2A, transcript variant X7
bromodomain adjacent to zinc finger domain 2A, transcript variant X2
bromodomain adjacent to zinc finger domain 2A, transcript variant X3
bromodomain adjacent to zinc finger domain protein 2A isoform X1
bromodomain adjacent to zinc finger domain protein 2A isoform X2
bromodomain adjacent to zinc finger domain protein 2A isoform X3
bromodomain adjacent to zinc finger domain protein 2A isoform X4
bromodomain adjacent to zinc finger domain protein 2A isoform X5
bromodomain adjacent to zinc finger domain 2A, transcript variant X8
bromodomain adjacent to zinc finger domain protein 2A isoform X6
RNA binding motif single stranded interacting protein 2, transcript variant X4
RNA binding motif single stranded interacting protein 2, transcript variant X3
RNA binding motif single stranded interacting protein 2, transcript variant X1
RNA binding motif single stranded interacting protein 2, transcript variant X2
RNA-binding motif, single-stranded-interacting protein 2 isoform X2
RNA-binding motif, single-stranded-interacting protein 2 isoform X1
RNA-binding motif, single-stranded-interacting protein 2 isoform X3
glutaminase liver isoform, mitochondrial isoform X1
glutaminase liver isoform, mitochondrial isoform X2
SPRY domain containing 4, transcript variant X3
SPRY domain containing 4, transcript variant X2
SPRY domain containing 4, transcript variant X1
SPRY domain-containing protein 4 isoform X3
SPRY domain-containing protein 4 isoform X2
SPRY domain-containing protein 4 isoform X1
timeless circadian regulator, transcript variant X1
timeless circadian regulator, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 431-like
zinc finger protein 431-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
zinc finger protein 431-like, transcript variant X2
zinc finger protein 431-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
thymocyte expressed, positive selection associated 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 10 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 98 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 18 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins
LOW QUALITY PROTEIN: mitochondrial fission regulator 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 89 Proteins, and 12% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 121 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
olfactory receptor 6C70-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 103 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
olfactory receptor 6C70-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
olfactory receptor 6C76, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 129 Proteins
olfactory receptor 6C76, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 130 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 6C65-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 21 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 106 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 124 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 114 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 124 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 68 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 119 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor 6C75-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 124 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 127 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 90 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 42 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 76 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 22% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 44 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 67 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 50 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 48 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 112 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 37 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 12 Proteins